Ethoxy acetalated dextran nanoparticles for drug delivery: A comparative study of formulation methods

Area of Science:

• Polymer chemistry
• Nanotechnology
• Pharmaceutical sciences

Background:

• Dextran-based polymers like ethoxy acetalated dextran (Ace-DEX) are explored for nanoparticle drug delivery.
• Ace-DEX offers tunable pH-dependent degradation and facile synthesis.
• Current research compares Ace-DEX with poly(lactic-co-glycolic acid) (PLGA) for drug encapsulation.

Purpose of the Study:

• To evaluate Ace-DEX nanoparticles as drug delivery vehicles.
• To compare Ace-DEX with PLGA for encapsulation efficiency.
• To investigate the impact of formulation techniques on nanoparticle properties and pharmaceutical production potential.

Main Methods:

• Preparation of BRP-187-loaded Ace-DEX nanoparticles using microfluidics, batch nanoprecipitation, and emulsion solvent evaporation.
• Characterization of physicochemical properties of the prepared nanoparticles.
• Evaluation of production methods for pharmaceutical scalability.

Main Results:

• Ace-DEX nanoparticles demonstrated competitive, and in some cases superior, encapsulation properties compared to PLGA.
• The choice of formulation technique influenced the physicochemical properties of the nanoparticles.
• Microfluidics, batch nanoprecipitation, and emulsion solvent evaporation were assessed for their suitability for large-scale production.

Conclusions:

• Ace-DEX is a viable alternative to PLGA for developing drug delivery nanoparticles.
• Formulation method selection is critical for optimizing nanoparticle characteristics and ensuring successful pharmaceutical translation.
• Further research is needed to identify the most scalable, reproducible, and cost-effective production method for Ace-DEX nanoparticles.